Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines

10.1097/inf.0000000000000897 ◽

2015 ◽

Vol 34 (12) ◽

pp. e298-e307 ◽

Cited By ~ 14

Author(s):

Timo Vesikari ◽

Aino Forsten ◽

Veronique Bianco ◽

Marie Van der Wielen ◽

Jacqueline M. Miller

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Primary Vaccination ◽

Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine

10.1097/inf.0b013e318269433a ◽

2012 ◽

pp. 1 ◽

Cited By ~ 2

Author(s):

Juan Carlos Tejedor ◽

José Manuel Merino ◽

Manuel Moro ◽

Maria-Luisa Navarro ◽

José Espín ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2020.1744363 ◽

2020 ◽

Vol 16 (6) ◽

pp. 1272-1279

Author(s):

Beatriz Quiambao ◽

Paula Peyrani ◽

Ping Li ◽

Mark W. Cutler ◽

Marie Van Der Wielen ◽

...

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Primary Vaccination ◽

Polysaccharide Vaccine ◽

Efficacy And Safety

Immunogenicity and Reactogenicity of a Booster Dose of a Novel Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Given to Toddlers of 13–14 Months of Age With Antibody Persistence Up to 31 Months of Age

10.1097/inf.0b013e31816b4561 ◽

2008 ◽

Vol 27 (7) ◽

pp. 579-588 ◽

Cited By ~ 26

Author(s):

Juan C. Tejedor ◽

Manuel Moro ◽

José Manuel Merino ◽

José Antonio Gómez-Campderá ◽

Manuel García-del-Rio ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Faculty Opinions recommendation of Antibody persistence and response to a booster dose of a quadrivalent conjugate vaccine for meningococcal disease in adolescents.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964465.793468640 ◽

2013 ◽

Author(s):

Bruce Brew ◽

Julia Thompson

Keyword(s):

Conjugate Vaccine ◽

Meningococcal Disease ◽

Booster Dose ◽

Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers

10.1097/inf.0000000000000898 ◽

2015 ◽

Vol 34 (12) ◽

pp. 1379-1384 ◽

Cited By ~ 4

Author(s):

Robert Booy ◽

Terry Nolan ◽

Graham Reynolds ◽

Peter Richmond ◽

Michael Nissen ◽

...

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Haemophilus Influenzae Type ◽

Haemophilus Influenzae Type B ◽

Type B ◽

Response letter: “Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules”

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2020.1798713 ◽

2020 ◽

Vol 16 (9) ◽

pp. 2282-2284

Author(s):

Marco Costantini ◽

Andrea Callegaro ◽

Jiří Beran ◽

Valérie Berlaimont ◽

Ilaria Galgani

Keyword(s):

Booster Dose ◽

Primary Vaccination ◽

Antibody Persistence ◽

Tick Borne Encephalitis ◽

Modeling Study

Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial

BMC Infectious Diseases ◽

10.1186/s12879-015-1138-y ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 14

Author(s):

Charissa Fay Corazon Borja-Tabora ◽

Cecilia Montalban ◽

Ziad A. Memish ◽

Dominique Boutriau ◽

Devayani Kolhe ◽

...

Keyword(s):

Single Dose ◽

Randomized Trial ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Adolescents And Adults

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years

Human Vaccines & Immunotherapeutics ◽

10.4161/hv.22165 ◽

2012 ◽

Vol 8 (12) ◽

pp. 1882-1891 ◽

Cited By ~ 22

Author(s):

Timo Vesikari ◽

Aino Forstén ◽

Dominique Boutriau ◽

Véronique Bianco ◽

Marie Van der Wielen ◽

...

Keyword(s):

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Randomized Study ◽

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

BMC Infectious Diseases ◽

10.1186/s12879-020-05104-5 ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Charissa Fay Corazon Borja-Tabora ◽

Paula Peyrani ◽

Chris Webber ◽

Marie Van der Wielen ◽

Brigitte Cheuvart ◽

...

Keyword(s):

Booster Dose ◽

Primary Vaccination ◽